Tibsovo and Bone pain - a phase IV clinical study of FDA data

Summary:

Bone pain is reported as a side effect among people who take Tibsovo (ivosidenib), especially for people who are have been taking the drug for 1 - 2 years also take Premarin, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Bone pain when taking Tibsovo. It is created by eHealthMe based on reports of 1,419 people who have side effects when taking Tibsovo from the FDA, and is updated regularly.

What is Tibsovo?

Tibsovo has active ingredients of ivosidenib. eHealthMe is studying from 1,420 Tibsovo users. Check the latest studies of Tibsovo.

What is Bone pain?

Bone pain is found to be associated with 1,814 drugs and 1,777 conditions by eHealthMe. Check the latest studies of Bone pain.



On Jul, 11, 2026

1,419 people reported to have side effects when taking Tibsovo.
Among them, 11 people (0.78%) have Bone pain.

Could Tibsovo cause Bone pain?

Among these 11 people:

How long have people been on Tibsovo when they have Bone pain? *

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 100 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What are other drugs people take besides Tibsovo? *

  1. Zoloft: 2 people, 18.18%
  2. Premarin: 2 people, 18.18%
  3. Vitamin C: 1 person, 9.09%
  4. Tylenol: 1 person, 9.09%
  5. Neulasta: 1 person, 9.09%
  6. Fish Oil: 1 person, 9.09%
  7. Ativan: 1 person, 9.09%

What are other side effects people have besides Bone pain? *

  1. Dyspnea (difficult or laboured breathing): 3 people, 27.27%
  2. Fatigue (feeling of tiredness): 2 people, 18.18%
  3. Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 18.18%
  4. Pain: 2 people, 18.18%
  5. Nightmares (unpleasant dreams): 2 people, 18.18%
  6. Nausea (feeling of having an urge to vomit): 2 people, 18.18%
  7. Joint Pain: 2 people, 18.18%
  8. White Blood Cell Count Abnormal: 1 person, 9.09%
  9. Back Pain: 1 person, 9.09%
  10. Blood Count Abnormal: 1 person, 9.09%

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 7 people, 63.64%
  2. Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 3 people, 27.27%
  3. Biliary Neoplasm (biliary tumour): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Tibsovo and have Bone pain?

- Check whether Bone pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tibsovo:

Bone pain treatments and more:

How severe was Bone pain and when was it recovered:

Expand to all the drugs that have ingredients of ivosidenib:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tibsovo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bone pain:

Browse all the conditions that are associated with Bone pain:


How the study uses the data?

The study uses data from the FDA. It is based on ivosidenib (the active ingredients of Tibsovo) and Tibsovo (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: